Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The impact of robotic‐assisted transperineal biopsy of the prostate on erectile function

The impact of robotic‐assisted transperineal biopsy of the prostate on erectile function INTRODUCTIONWorldwide prostate cancer (PCa) is the second most common malignant disease in men and its histological confirmation by biopsy remains essential for therapy decisions.1 Different approaches and techniques have been described2 and alone in Europe and the United States more than 2 million procedures are carried out every year. This high frequency presupposes a precise knowledge of possible complications to facilitate selection of an appropriate biopsy method.3 Especially extensive or repeated biopsies may lead to a decrease of erectile function (EF) attributable to the acute healing phase after the procedure or anxiety related to a possible cancer diagnosis.4,5 These impacts of either TRUS‐guided transrectal (TRBx) or perineal biopsies (TPBx) have been assessed by some authors,5–9 but the data are sparse and heterogenous and there is a lack of information for newly introduced minimal invasive approaches.4,9Male erectile dysfunction (ED) is defined as a persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance.10 For assessment of ED severity, the International Index of Erectile Function‐5 (IIEF‐5) questionnaire is in regular use.5 Significant decrease of IIEF‐5 1 month after biopsy was demonstrated for both, TRBx and TPBx,9 however technique or number of biopsy cores showed no significant impact http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Andrology Wiley

The impact of robotic‐assisted transperineal biopsy of the prostate on erectile function

Download PDF
7 pages

Loading next page...
 
/lp/wiley/the-impact-of-robotic-assisted-transperineal-biopsy-of-the-prostate-on-XwH8QtkP3o
Publisher
Wiley
Copyright
© 2023 American Society of Andrology and European Academy of Andrology.
ISSN
2047-2919
eISSN
2047-2927
DOI
10.1111/andr.13346
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONWorldwide prostate cancer (PCa) is the second most common malignant disease in men and its histological confirmation by biopsy remains essential for therapy decisions.1 Different approaches and techniques have been described2 and alone in Europe and the United States more than 2 million procedures are carried out every year. This high frequency presupposes a precise knowledge of possible complications to facilitate selection of an appropriate biopsy method.3 Especially extensive or repeated biopsies may lead to a decrease of erectile function (EF) attributable to the acute healing phase after the procedure or anxiety related to a possible cancer diagnosis.4,5 These impacts of either TRUS‐guided transrectal (TRBx) or perineal biopsies (TPBx) have been assessed by some authors,5–9 but the data are sparse and heterogenous and there is a lack of information for newly introduced minimal invasive approaches.4,9Male erectile dysfunction (ED) is defined as a persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance.10 For assessment of ED severity, the International Index of Erectile Function‐5 (IIEF‐5) questionnaire is in regular use.5 Significant decrease of IIEF‐5 1 month after biopsy was demonstrated for both, TRBx and TPBx,9 however technique or number of biopsy cores showed no significant impact

Journal

Andrology – Wiley

Published: Sep 1, 2023

Keywords: erectile dysfunction; erectile function; minimal‐invasive; prostate biopsy; robotic‐assisted; transperineal

References

  • EAU‐ESTRO‐SIOG Guidelines on Prostate Cancer. Part 1: screening, diagnosis, and local treatment with curative intent
    Mottet, N; Bellmunt, J; Bolla, M
  • Feasibility of freehand MRI/US cognitive fusion transperineal biopsy of the prostate in local anaesthesia as in‐office procedure‐experience with 400 patients
    Wetterauer, C; Shahin, O; Federer‐Gsponer, JR
  • Complications after systematic, random, and image‐guided prostate biopsy
    Borghesi, M; Ahmed, H; Nam, R
  • Systematic review of complications of prostate biopsy
    Loeb, S; Vellekoop, A; Ahmed, HU
  • Erectile function in prostate cancer‐free patients who underwent prostate saturation biopsy
    Akbal, C; Türker, P; Tavukçu, HH; Simşek, F; Türkeri, L
  • Can prostate biopsies affect erectile function?
    Chrisofos, M; Papatsoris, AG; Dellis, A; Varkarakis, IM; Skolarikos, A; Deliveliotis, C
  • Impact of transperineal prostate biopsy on erectile function: a prospective study using the international index of erectile function (IIEF)
    Galfano, A; Novara, G; Salvetti, M; Agostini, A; Ficarra, V; Artibani, W
  • The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety
    Glaser, AP; Novakovic, K; Helfand, BT
  • Erectile dysfunction is a transient complication of prostate biopsy: a systematic review and meta‐analysis
    Fainberg, J; Gaffney, CD; Pierce, H
  • Impotence. NIH consensus development panel on impotence
  • Assessment of the influence of transrectal and transperineal prostate biopsies on erectile function: a prospective observational single‐center study
    García Rojo, E; García Gómez, B; González Padilla, DA
  • Robotic transrectal ultrasound guided prostate biopsy
    Lim, S; Jun, C; Chang, D; Petrisor, D; Han, M; Stoianovici, D
  • Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 4: transperineal magnetic resonance‐ultrasound fusion guided biopsy using local anesthesia
    Immerzeel, J; Israël, B; Bomers, J
  • The impact of transrectal prostate needle biopsy on sexuality in men and their female partners
    Tuncel, A; Kirilmaz, U; Nalcacioglu, V; Aslan, Y; Polat, F; Atan, A
  • Development and evaluation of an abridged, 5‐item version of the international index of erectile function (IIEF‐5) as a diagnostic tool for erectile dysfunction
    Rosen, RC; Cappelleri, JC; Smith, MD; Lipsky, J; Peña, BM
  • Aging related erectile dysfunction‐potential mechanism to halt or delay its onset
    Ferrini, MG; Gonzalez‐Cadavid, NF; Rajfer, J
  • Diagnostic accuracy and clinical implications of robotic assisted MRI‐US fusion guided target saturation biopsy of the prostate
    Wetterauer, C; Trotsenko, P; Matthias, MO
  • The impact of prostate biopsy on patient well‐being: a prospective study of pain, anxiety and erectile dysfunction
    Zisman, A; Leibovici, D; Kleinmann, J; Siegel, YI; Lindner, A
  • The impact of prostate biopsy and periprostatic nerve block on erectile and voiding function: a prospective study
    Klein, T; Palisaar, RJ; Holz, A; Brock, M; Noldus, J; Hinkel, A
  • Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance
    Fujita, K; Landis, P; McNeil Brian, K; Pavlovich, CP
  • Effect of repeated prostate biopsies on erectile function in men on active surveillance for prostate cancer
    Braun, K; Ahallal, Y; Sjoberg, DD
  • Serial transperineal sector prostate biopsies: impact on long‐term erectile dysfunction
    Chong, JJ; Van Hemelrijck, M; Cahill, D; Kinsella, J